Simplify Logo

Full-Time

Sr. Research Associate

RNA Science

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Healthcare
Biotechnology

Junior

Cambridge, MA, USA

70% in-office presence required.

Category
Bioinformatics
Computational Biology
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • BS or MS in Biology, Chemistry, Biochemistry, or Bioengineering-related field with at least 2 years of industry experience
  • Experience with mammalian cell culture and transfection techniques
  • Experience with protein and RNA quantification methods such as live cell imaging, western blotting, ELISA assays, and qPCR.
  • Ability to participate in multiple collaborative projects in a cross-functional team environment
  • Ability to multi-task to meet research goals
  • Strong quantitative analysis skills
  • Excellent written and oral communication
Responsibilities
  • Design, conduct and troubleshoot in vitro/ex vivo/cell-based RNA and protein experiments
  • Perform multiple biological techniques, including tissue culture, cell transfection, live cell imaging, qPCR, flow cytometry, western blots, ELISAs, capillary electrophoresis, and other biochemical assays.
  • Contribute to data analysis and interpretation of study results.
  • Interpret, summarize, and present experimental data and results at group meetings, project meetings, and department meetings.
  • Keep careful data records (electronic lab notebook and others)

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

8%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.